Correspondence 0001193125-23-277878 from IGM Biosciences, Inc. (IGMS) (CIK 0001496323)
IGM Biosciences, Inc. (IGMS) (CIK 0001496323)
Date: Nov. 15, 2023 · CIK: 0001496323 · Accession: 0001193125-23-277878
AI Filing Summary & Sentiment
File numbers found in text: 333-275519
Letter
IGM Biosciences, Inc.
325 E. Middlefield Road
Mountain View, CA 94043
November 15,
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Joshua Gorsky
Re: IGM Biosciences, Inc.
Registration Statement on Form S-3
File No. 333-275519
Acceleration Request
Requested Date: November 17, 2023
Requested Time: 4:00 p.m.
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, IGM Biosciences, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-275519) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with the Company’s counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Jennifer Knapp at (650) 849-3041 or, in her absence, James Babikian at (206) 670-2833.
[Signature page follows]
Sincerely,
IGM Biosciences, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP IGM Biosciences, Inc. 325 E. Middlefield Road Mountain View, CA 94043 November 15, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: IGM Biosciences, Inc. Registration Statement on Form S-3 File No. 333-275519 Acceleration Request Requested Date: November 17, 2023 Requested Time: 4:00 p.m. Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, IGM Biosciences, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-275519) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with the Company’s counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Jennifer Knapp at (650) 849-3041 or, in her absence, James Babikian at (206) 670-2833. [Signature page follows] Sincerely, IGM Biosciences, Inc. /s/ Paul Graffagnino Paul Graffagnino Senior Vice President, Legal Affairs cc: Fred Schwarzer, IGM Biosciences, Inc. Misbah Tahir, IGM Biosciences, Inc. Tony Jeffries, Wilson Sonsini Goodrich & Rosati, P.C. Jennifer Knapp, Wilson Sonsini Goodrich & Rosati, P.C. Christina Poulsen, Wilson Sonsini Goodrich & Rosati, P.C. James Babikian, Wilson Sonsini Goodrich & Rosati, P.C.